Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids.

Doleželová Š, Jíchová Š, Husková Z, Vojtíšková A, Kujal P, Hošková L, Kautzner J, Sadowski J, Červenka L, Kopkan L.

Clin Exp Hypertens. 2016;38(7):644-651. Epub 2016 Sep 26.

PMID:
27669111
2.

Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system.

Hošková L, Málek I, Kautzner J, Honsová E, van Dokkum RP, Husková Z, Vojtíšková A, Varcabová S, Cervenka L, Kopkan L.

Hypertens Res. 2014 Aug;37(8):724-32. doi: 10.1038/hr.2014.79. Epub 2014 Apr 10.

PMID:
24718302
3.

Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.

Kopkan L, Husková Z, Sporková A, Varcabová Š, Honetschlägerová Z, Hwang SH, Tsai HJ, Hammock BD, Imig JD, Kramer HJ, Bürgelová M, Vojtíšková A, Kujal P, Vernerová Z, Červenka L.

Kidney Blood Press Res. 2012;35(6):595-607. doi: 10.1159/000339883. Epub 2012 Aug 29.

4.

Structure, dynamics, and hydration of POPC/POPS bilayers suspended in NaCl, KCl, and CsCl solutions.

Jurkiewicz P, Cwiklik L, Vojtíšková A, Jungwirth P, Hof M.

Biochim Biophys Acta. 2012 Mar;1818(3):609-16. doi: 10.1016/j.bbamem.2011.11.033. Epub 2011 Dec 6.

5.

HIF and reactive oxygen species regulate oxidative phosphorylation in cancer.

Hervouet E, Cízková A, Demont J, Vojtísková A, Pecina P, Franssen-van Hal NL, Keijer J, Simonnet H, Ivánek R, Kmoch S, Godinot C, Houstek J.

Carcinogenesis. 2008 Aug;29(8):1528-37. doi: 10.1093/carcin/bgn125. Epub 2008 May 29.

PMID:
18515279
6.

Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains.

Pravenec M, Hyakukoku M, Houstek J, Zidek V, Landa V, Mlejnek P, Miksik I, Dudová-Mothejzikova K, Pecina P, Vrbacky M, Drahota Z, Vojtiskova A, Mracek T, Kazdova L, Oliyarnyk O, Wang J, Ho C, Qi N, Sugimoto K, Kurtz T.

Genome Res. 2007 Sep;17(9):1319-26. Epub 2007 Aug 10. Erratum in: Genome Res. 2008 Oct;18(10):1680.

7.

Respiratory chain components involved in the glycerophosphate dehydrogenase-dependent ROS production by brown adipose tissue mitochondria.

Vrbacký M, Drahota Z, Mrácek T, Vojtísková A, Jesina P, Stopka P, Houstek J.

Biochim Biophys Acta. 2007 Jul;1767(7):989-97. Epub 2007 May 13.

8.

Mitochondrial complex I inhibition in cerebral cortex of immature rats following homocysteic acid-induced seizures.

Folbergrová J, Jesina P, Drahota Z, Lisý V, Haugvicová R, Vojtísková A, Houstĕk J.

Exp Neurol. 2007 Apr;204(2):597-609. Epub 2006 Dec 19.

PMID:
17270175
9.

Mitochondrial diseases and genetic defects of ATP synthase.

Houstek J, Pícková A, Vojtísková A, Mrácek T, Pecina P, Jesina P.

Biochim Biophys Acta. 2006 Sep-Oct;1757(9-10):1400-5. Epub 2006 Apr 19. Review.

10.

Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride.

Hervouet E, Pecina P, Demont J, Vojtísková A, Simonnet H, Houstek J, Godinot C.

Biochem Biophys Res Commun. 2006 Jun 16;344(4):1086-93. Epub 2006 Apr 19.

PMID:
16643849
11.

Evaluation of mitochondrial membrane potential using a computerized device with a tetraphenylphosphonium-selective electrode.

Labajova A, Vojtiskova A, Krivakova P, Kofranek J, Drahota Z, Houstek J.

Anal Biochem. 2006 Jun 1;353(1):37-42. Epub 2006 Apr 18.

PMID:
16643832
12.

Two components in pathogenic mechanism of mitochondrial ATPase deficiency: energy deprivation and ROS production.

Mrácek T, Pecina P, Vojtísková A, Kalous M, Sebesta O, Houstek J.

Exp Gerontol. 2006 Jul;41(7):683-7. Epub 2006 Apr 3.

PMID:
16581217
13.

Flow-cytometric monitoring of mitochondrial depolarisation: from fluorescence intensities to millivolts.

Plásek J, Vojtísková A, Houstek J.

J Photochem Photobiol B. 2005 Feb 1;78(2):99-108.

PMID:
15664496
14.

A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis.

Hervouet E, Demont J, Pecina P, Vojtísková A, Houstek J, Simonnet H, Godinot C.

Carcinogenesis. 2005 Mar;26(3):531-9. Epub 2004 Dec 16.

PMID:
15604095
15.

Mitochondrial diseases and ATPase defects of nuclear origin.

Houstek J, Mrácek T, Vojtísková A, Zeman J.

Biochim Biophys Acta. 2004 Jul 23;1658(1-2):115-21. Review.

16.

Diminished synthesis of subunit a (ATP6) and altered function of ATP synthase and cytochrome c oxidase due to the mtDNA 2 bp microdeletion of TA at positions 9205 and 9206.

Jesina P, Tesarová M, Fornůsková D, Vojtísková A, Pecina P, Kaplanová V, Hansíková H, Zeman J, Houstek J.

Biochem J. 2004 Nov 1;383(Pt. 3):561-71.

17.

Mitochondrial membrane potential and ATP production in primary disorders of ATP synthase.

Vojtísková A, Jesina P, Kalous M, Kaplanová V, Houstek J, Tesarová M, Fornůsková D, Zeman J, Dubot A, Godinot C.

Toxicol Mech Methods. 2004;14(1-2):7-11. doi: 10.1080/15376520490257347.

PMID:
20021115
18.

GUG is an efficient initiation codon to translate the human mitochondrial ATP6 gene.

Dubot A, Godinot C, Dumur V, Sablonnière B, Stojkovic T, Cuisset JM, Vojtiskova A, Pecina P, Jesina P, Houstek J.

Biochem Biophys Res Commun. 2004 Jan 16;313(3):687-93.

PMID:
14697245
19.

Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome.

Pecina P, Capková M, Chowdhury SK, Drahota Z, Dubot A, Vojtísková A, Hansíková H, Houst'ková H, Zeman J, Godinot C, Houstek J.

Biochim Biophys Acta. 2003 Sep 1;1639(1):53-63.

20.

Glycerophosphate-dependent peroxide production by brown fat mitochondria from newborn rats.

Drahota Z, Rauchova H, Jesina P, Vojtísková A, Houstek J.

Gen Physiol Biophys. 2003 Mar;22(1):93-102.

Supplemental Content

Loading ...
Support Center